Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P)+ transhydrogenase enzyme
AssigneeCargill, Incorporated
InventorsBrian J. Rush, Kevin T. Watts, Vernon L. McIntosh, Jr., Arlene M. Fosmer, Gregory M. Poynter, Thomas W. McMullin
Life of this patent
Estimating the term…
Abstract
Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.
Claims1
A fermentation broth comprising at least one carbon source and recombinant yeast cells engineered to produce succinate through an active reductive tricarboxylic acid (TCA) pathway from pyruvate or phosphoenolpyruvate, wherein the recombinant yeast cells are genetically modified to express a soluble nicotinamide adenine dinucleotide phosphate (NAD(P)+) transhydrogenase enzyme in the cytosol of the yeast cells by having integrated into their genomes an exogenous gene encoding the soluble NAD(P)+ transhydrogenase enzyme, wherein the recombinant yeast cells are further modified by having integrated into their genomes at least one of:
- (i) an exogenous pyruvate carboxylase gene that encodes an enzyme which catalyzes the conversion of pyruvate to oxaloacetate;
- (ii) an exogenous malate dehydrogenase gene which encodes an enzyme that catalyzes the conversion of oxaloacetate to malate;
- (iii) an exogenous fumarase gene that encodes an enzyme which catalyzes the conversion of malate to fumarate;
- and
- (iv) an exogenous fumarate reductase gene which encodes an enzyme which catalyzes the conversion of fumarate to succinate, and
- wherein the recombinant yeast cells produce more succinate through the active reductive TCA pathway as compared to a corresponding parent yeast cell lacking the soluble NAD(P)+ transhydrogenase enzyme.
Dependencies are inferred from the claim text.